Duane Nash - Net Worth and Insider Trading
Duane Nash Net Worth
The estimated net worth of Duane Nash is at least $47,985 dollars as of 2024-05-01. Duane Nash is the Director of Akebia Therapeutics Inc and owns about 21,499 shares of Akebia Therapeutics Inc (AKBA) stock worth over $27,304. Duane Nash is also the Executive Chairman of Immunic Inc and owns about 16,032 shares of Immunic Inc (IMUX) stock worth over $20,681. Details can be seen in Duane Nash's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Duane Nash has not made any transactions after 2022-05-12 and currently still holds the listed stock(s).
Transaction Summary of Duane Nash
Duane Nash Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Duane Nash owns 2 companies in total, including Immunic Inc (IMUX) , and Akebia Therapeutics Inc (AKBA) .
Click here to see the complete history of Duane Nash’s form 4 insider trades.
Insider Ownership Summary of Duane Nash
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IMUX | Immunic Inc | 2022-05-12 | director |
| AKBA | Akebia Therapeutics Inc | 2018-02-15 | director |
Duane Nash Latest Holdings Summary
Duane Nash currently owns a total of 2 stocks. Among these stocks, Duane Nash owns 21,499 shares of Akebia Therapeutics Inc (AKBA) as of February 15, 2018, with a value of $27,304 and a weighting of 56.9%. Duane Nash also owns 16,032 shares of Immunic Inc (IMUX) as of May 12, 2022, with a value of $20,681 and a weighting of 43.1%.
Latest Holdings of Duane Nash
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2018-02-15 | 21,499 | 1.27 | 27,304 |
| IMUX | Immunic Inc | 2022-05-12 | 16,032 | 1.29 | 20,681 |
Holding Weightings of Duane Nash
Duane Nash Form 4 Trading Tracker
According to the SEC Form 4 filings, Duane Nash has made a total of 0 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years. The most-recent trade in Akebia Therapeutics Inc is the sale of 1,000 shares on February 15, 2018, which brought Duane Nash around $14,620.
According to the SEC Form 4 filings, Duane Nash has made a total of 4 transactions in Immunic Inc (IMUX) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Immunic Inc is the acquisition of 10,000 shares on May 12, 2022, which cost Duane Nash around $50,300.
Insider Trading History of Duane Nash
- 1
Duane Nash Trading Performance
GuruFocus tracks the stock performance after each of Duane Nash's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Duane Nash is -1.91%. GuruFocus also compares Duane Nash's trading performance to market benchmark return within the same time period. The performance of stocks bought by Duane Nash within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Duane Nash's insider trading performs compared to the benchmark.
Performance of Duane Nash
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.78 | | | | | |
| Relative Return to S&P 500(%) | -8.76 | | | | | |
Duane Nash Ownership Network
Duane Nash Owned Company Details
What does Immunic Inc do?
Who are the key executives at Immunic Inc?
Duane Nash is the director of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .
Immunic Inc (IMUX) Insider Trades Summary
Over the past 18 months, Duane Nash made no insider transaction in Immunic Inc (IMUX). Other recent insider transactions involving Immunic Inc (IMUX) include a net purchase of 100,000 shares made by Joerg Neermann , a net purchase of 22,000 shares made by Daniel Vitt , and a net purchase of 10,000 shares made by Glenn Whaley .
In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc (IMUX) in total and bought 14,000 shares, with a net purchase of 14,000 shares. During the past 18 months, 0 shares of Immunic Inc (IMUX) were sold and 132,000 shares were bought by its insiders, resulting in a net purchase of 132,000 shares.
Immunic Inc (IMUX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunic Inc Insider Transactions
Duane Nash Mailing Address
Above is the net worth, insider trading, and ownership report for Duane Nash. You might contact Duane Nash via mailing address: C/o Vital Therapies, Inc., 15010 Avenue Of Science, Suite 200, San Diego Ca 92128.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
